Skip to main content
. 2017 Dec 27;4(2):e000699. doi: 10.1136/openhrt-2017-000699

Table 1.

Demographic, clinical, microbiology and echocardiographic characteristics of patients with definite endocarditis according to study period

Variable Pre-ET
(n=101)
Post-ET
(n=95)
P value
Age (years) 56.1±14.4 57.5±17.5 0.54
Male 67 (66.3) 73 (76.8) 0.12
Diabetes mellitus 14 (13.9) 15 (15.8) 0.84
EuroSCORE II 11.7±10.6 13.1±10.3 0.35
Biochemical results*
 Serum eGFR (mL/min) 66.8±26.1 66.3±25.1 0.91
 Serum haemoglobin (g/dL) 91.5±32.7 89.6±32.2 0.70
 Serum neutrophils (x109/L) 9.1±5.3 8.2±5.1 0.23
 Serum CRP (mg/L) 93.4±66.1 105.5±90.5 0.29
Predisposing conditions for IE
 Predisposing cardiac disease† 30 (29.7) 26 (27.4) 0.75
 Intravenous drug abuse 10 (9.9) 9 (9.5) 1.00
 History of IE 10 (9.9) 9 (9.5) 1.00
 Intervention (12 months)‡ 21 (20.8) 14 (14.7) 0.35
Localisation of vegetation
 AV 39 (38.6) 38 (40.0) 0.96
 AV+aortic root 9 (8.9) 8 (8.4)
 MV 29 (28.7) 27 (28.4)
 AV+MV 7 (6.9) 8 (8.4)
 TV 11 (10.9) 8 (8.4)
 AV+MV+TV 2 (2) 3 (3.2)
 Pacemaker lead (no valve) 1 (1) 2 (2.1)
 No vegetation identified 3 (3.0) 1 (1.1)
Valve type
 Native 71 (70.3) 68 (71.6) 1.00
 Prosthetic 22 (21.8) 22 (23.2)
 Native and prosthetic 4 (4.0) 2 (2.1)
Microbiology
 Blood culture positive 82 (81.2) 85 (89.5) 0.11
 Viridans group streptococci 14 (13.9) 9 (9.5) 0.50
Streptococcus gallolyticus 6 (5.9)s3 (3.2)
Staphylococcus aureus 24 (23.8) 27 (28.4)
 Enterococci 9 (8.9) 11 (11.6)

Data shown as mean±SD or number (percentage).

*Admission values.

†Rheumatic disease, prosthetic valve or valve repair.

‡Dental or surgical interventions within the past 12 months.

AV, aortic valve; CRP, C-reactive protein; eGFR, estimated glomerular filtration rate; ET, endocarditis team; EuroSCORE, European System for Cardiac Operative Risk Evaluation; IE, infective endocarditis; MV, mitral valve; TV, tricuspid valve.